↓ Direkt till sidans innehåll
↓ Direkt till sidans sekundära innehåll (sidomenyn)

Träfflista för sökning "WFRF:(Svenningsson P) ;mspu:(article)"

Sökning: WFRF:(Svenningsson P) > Tidskriftsartikel

Resultat 1-10 av 392

Sortera/gruppera träfflistan

Sortering: Träffar per sida:

Numrering	Referens	Omslagsbild	Hitta
1.	Braisch, U, et al. (författare) Identification of symbol digit modality test score extremes in Huntington's disease 2019 Ingår i: American journal of medical genetics. Part B, Neuropsychiatric genetics : the official publication of the International Society of Psychiatric Genetics. - : Wiley. - 1552-485X .- 1552-4841. ; 180:3, s. 232-245 Tidskriftsartikel (refereegranskat)
2.	Orth, M, et al. (författare) Observing Huntington's disease: the European Huntington's Disease Network's REGISTRY 2011 Ingår i: Journal of neurology, neurosurgery, and psychiatry. - : BMJ. - 1468-330X .- 0022-3050. ; 82:12, s. 1409- Tidskriftsartikel (övrigt vetenskapligt/konstnärligt)
3.	Choularton, T. W., et al. (författare) The Great Dun Fell Cloud Experiment 1993 : An overview 1997 Ingår i: Atmospheric Environment. - 1352-2310. ; 31:16, s. 2393-2405 Tidskriftsartikel (refereegranskat)abstract The 1993 Ground-based Cloud Experiment on Great Dun Fell used a wide range of measurements of trace gases, aerosol particles and cloud droplets at five sites to study their sources and sinks especially those in cloud. These measurements have been interpreted using a variety of models. The conclusions add to our knowledge of air pollution, acidification of the atmosphere and the ground, eutrophication and climate change. The experiment is designed to use the hill cap cloud as a flow-through reactor, and was conducted in varying levels of pollution typical of much of the rural temperate continental northern hemisphere in spring-time.
4.	Salzer, J., et al. (författare) Rituximab in multiple sclerosis 2016 Ingår i: Neurology. - 0028-3878. ; 87:20, s. 2074-2081 Tidskriftsartikel (refereegranskat)abstract Objective: To investigate the safety and efficacy of rituximab in multiple sclerosis (MS). Methods: In this retrospective uncontrolled observational multicenter study, off-label rituximab-treated patients with MS were identified through the Swedish MS register. Outcome data were collected from the MS register and medical charts. Adverse events (AEs) grades 2-5 according to the Common Terminology Criteria for Adverse Events were recorded. Results: A total of 822 rituximab-treated patients with MS were identified: 557 relapsing-remitting MS (RRMS), 198 secondary progressive MS (SPMS), and 67 primary progressive MS (PPMS). At baseline, 26.2% had contrast-enhancing lesions (CELs). Patients were treated with 500 or 1,000 mg rituximab IV every 6-12 months, during a mean 21.8 (SD 14.3) months. During treatment, the annualized relapse rates were 0.044 (RRMS), 0.038 (SPMS), and 0.015 (PPMS), and 4.6% of patients displayed CELs. Median Expanded Disability Status Scale remained unchanged in RRMS (p 0.42) and increased by 0.5 and 1.0 in SPMS and PPMS, respectively (p 0.10 and 0.25). Infusion-related AEs occurred during 7.8% of infusions and most were mild. A total of 89 AEs grades ≥2 (of which 76 infections) were recorded in 72 patients. No case of progressive multifocal leukoencephalopathy was detected. Conclusions: This is the largest cohort of patients with MS treated with rituximab reported so far. The safety, clinical, and MRI findings in this heterogeneous real-world cohort treated with different doses of rituximab were similar to those reported in previous randomized controlled trials on B-cell depletion therapy in MS. Classification of evidence: This study provides Class IV evidence that for patients with MS, rituximab is safe and effective. © 2016 American Academy of Neurology.
5.	Allen, PB, et al. (författare) Distinct roles for spinophilin and neurabin in dopamine-mediated plasticity 2006 Ingår i: Neuroscience. - : Elsevier BV. - 0306-4522. ; 140:3, s. 897-911 Tidskriftsartikel (refereegranskat)
6.	Haack, TB, et al. (författare) Absence of the Autophagy Adaptor SQSTM1/p62 Causes Childhood-Onset Neurodegeneration with Ataxia, Dystonia, and Gaze Palsy 2016 Ingår i: American journal of human genetics. - : Elsevier BV. - 1537-6605 .- 0002-9297. ; 99:3, s. 735-743 Tidskriftsartikel (refereegranskat)
7.	Hsu, SC, et al. (författare) Mutations in SLC20A2 are a major cause of familial idiopathic basal ganglia calcification 2013 Ingår i: Neurogenetics. - : Springer Science and Business Media LLC. - 1364-6753 .- 1364-6745. ; 14:1, s. 11-22 Tidskriftsartikel (refereegranskat)
8.	Jucaite, A, et al. (författare) Glia Imaging Differentiates Multiple System Atrophy from Parkinson's Disease: A Positron Emission Tomography Study with [11 C]PBR28 and Machine Learning Analysis 2022 Ingår i: Movement disorders : official journal of the Movement Disorder Society. - : Wiley. - 1531-8257. ; 37:1, s. 119-129 Tidskriftsartikel (refereegranskat)
9.	Kulmala, M., et al. (författare) Overview of the BACCI (Biosphere-Atmosphere-Cloud-Climate Interactions) studies 2008 Ingår i: Tellus B. - : Stockholm University Press. ; 6:3, s. 300-317 Tidskriftsartikel (refereegranskat)
10.	Lacivita, E, et al. (författare) Investigations on the 1-(2-biphenyl)piperazine motif: identification of new potent and selective ligands for the serotonin(7) (5-HT(7)) receptor with agonist or antagonist action in vitro or ex vivo 2012 Ingår i: Journal of medicinal chemistry. - : American Chemical Society (ACS). - 1520-4804 .- 0022-2623. ; 55:14, s. 6375-6380 Tidskriftsartikel (refereegranskat)

Skapa referenser, mejla, bekava och länka

Länka till träfflistan

Resultat 1-10 av 392

Avgränsa träffmängd

Typ av publikation: tidskriftsartikel (392)Ta bort avgränsningen

Typ av innehåll: refereegranskat (316); övrigt vetenskapligt/konstnärligt (76)

Författare/redaktör: Svenningsson, P (315); Piehl, F (51); Svenningsson, A (49); Paucar, M (47); Nilsson, P. (44); Lycke, J (44); visa fler...; Hillert, J (43); Olsson, T (43); Dahle, C. (41); Martin, C (40); Fredholm, BB (40); Burman, J. (37); Gunnarsson, Martin, ... (32); Landtblom, A. -M (32); Forsberg, L. (30); Sundström, P. (30); Kågström, S. (29); Greengard, P (26); Zhang, XQ (25); Markaki, I (20); Fält, A. (16); Paslawski, W (16); Berglund, A. (14); Varrone, A (13); Tsitsi, P. (13); Halldin, C (11); Svenningsson, Anders (11); SOLDERS, G (11); Andreasson, M (10); Fazio, P (10); Aarsland, D (9); Johansson, A (9); Farde, L (9); Fink, K (9); Frisell, T (9); NOMIKOS, GG (9); Fisone, G (8); Kull, B (8); Hertz, E. (8); Ogren, SO (7); Nilsson, D (7); Spedding, M (7); Eriksson, TM (7); Granberg, T (7); Alping, P (7); Millan, MJ (7); Svenningsson, B. (7); Cselenyi, Z (7); Laffita-Mesa, JM (7); Khosousi, S (7); visa färre...

Lärosäte: Karolinska Institutet (333); Örebro universitet (33); Göteborgs universitet (23); Umeå universitet (23); Lunds universitet (22); Uppsala universitet (19); visa fler...; Stockholms universitet (5); Linköpings universitet (5); Kungliga Tekniska Högskolan (4); Mittuniversitetet (2); Linnéuniversitetet (2); Chalmers tekniska högskola (1); RISE (1); Marie Cederschiöld högskola (1); visa färre...

Språk: Engelska (391); Svenska (1)

Forskningsämne (UKÄ/SCB): Medicin och hälsovetenskap (88); Naturvetenskap (14); Teknik (4)

År

Kungliga biblioteket hanterar dina personuppgifter i enlighet med EU:s dataskyddsförordning (2018), GDPR. Läs mer om hur det funkar här.
Så här hanterar KB dina uppgifter vid användning av denna tjänst.

Copyright © LIBRIS - Nationella bibliotekssystem
LIBRIS.kb.se

pil uppåt

Stäng

Kopiera och spara länken för att återkomma till aktuell vy